SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year gross profit growth rate
Latest
0.28%
↓ 100% vs avg
Percentile
P60
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
262.69%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.28% |
| Q3 2025 | 6.88% |
| Q2 2025 | -5.61% |
| Q1 2025 | -15.99% |
| Q4 2024 | 30.60% |
| Q3 2024 | -27.41% |
| Q2 2024 | 27.04% |
| Q1 2024 | -62.78% |
| Q4 2023 | -326.66% |
| Q3 2023 | 134.94% |
| Q2 2023 | -135.84% |
| Q1 2023 | -127.65% |
| Q4 2022 | -53.83% |
| Q3 2022 | 219.96% |
| Q2 2022 | -118.93% |
| Q1 2022 | 2776.45% |
| Q4 2021 | -97.12% |
| Q3 2021 | 3111.18% |
| Q2 2021 | -111.43% |
| Q1 2021 | 292.51% |
| Q4 2020 | 0.00% |